Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 148,489 | 141,077 | 145,587 | 166,460 | 128,568 |
| Cost of Goods | 90,618 | 76,926 | 67,560 | 88,637 | 66,015 |
| Gross Profit | 57,871 | 64,151 | 78,027 | 77,823 | 62,553 |
| Operating Expenses | 54,218 | 60,180 | 49,128 | 48,290 | 44,102 |
| Operating Income | 4,271 | 4,897 | 29,459 | 30,170 | 18,466 |
| Interest Expense | 283 | 25 | 145 | 423 | 39 |
| Other Income | 149,732 | 199 | 358 | 187 | 207 |
| Pre-tax Income | 153,720 | 5,071 | 29,672 | 29,934 | 18,634 |
| Income Tax | 48,278 | 272 | 9,635 | 11,262 | 6,269 |
| Net Income Continuous | 105,442 | 4,799 | 20,037 | 18,672 | 12,365 |
| Net Income | $105,442 | $4,799 | $20,037 | $18,672 | $12,365 |
| EPS Basic Total Ops | 1.59 | 0.07 | 0.30 | 0.29 | 0.19 |
| EPS Basic Continuous Ops | 1.59 | 0.07 | 0.30 | 0.29 | 0.19 |
| EPS Diluted Total Ops | 1.55 | 0.08 | 0.29 | 0.27 | 0.18 |
| EPS Diluted Continuous Ops | 1.55 | 0.07 | 0.29 | 0.27 | 0.18 |
| EBITDA(a) | $16,668 | $68,452 | $31,822 | $49,464 | $22,857 |